Acquisitions and spinoffs in 2025 surpassed the previous three years, according to a report from Bain & Company.
A fault in J&J MedTech’s CEREPAK detachable coils, used in intracranial aneurysm embolisation procedures, has been associated ...
Medtech startups struggle with funding as strategic buyers consolidate, preferring fully developed products over early ...
The FDA has flagged J&J Medtech’s recall of its Cerepak detachable coils as Class I in the wake of one death and four serious ...
Discover how global tariffs are driving changes in medtech growth strategies, M&A activities, and manufacturing footprints.
Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have ...
Johnson & Johnson MedTech (NYSE:JNJ) today announced 12-month pilot data from a study of its investigational Omnypulse ...
While in 2025 med-tech financings averaged $3.3 billion per month, January 2026 saw the sector bring in $1.52 billion across 39 transactions. It was the lowest monthly total since November 2024’s $924 ...
The medical technology investment space is a pretty small ecosystem, according to medtech venture capitalist Maria Berkman. “The number of venture funds that exclusively focus on medtech is relatively ...
Aztron Medtech, a privately held orthopedic device company, today announced that more than 100 clinical procedures have now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results